Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
01 July 2020Website:
http://www.accolade.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:18:47 GMTDividend
Analysts recommendations
Institutional Ownership
ACCD Latest News
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The tech and health company's fiscal-year earnings report weighs on shares.
Accolade's full-year guidance was mixed, notwithstanding a Q1 FY 2025 results beat driven by a favorable timing factor. ACCD sees its revenue growth slowing from +14% last year to +13% in the current fiscal year, but its 3.7% FY 2025 EBITDA margin guidance was above expectations. My rating for Accolade is downgraded from a Buy to a Hold, after considering the company's outlook in light of its updated guidance.
LOS ANGELES--(BUSINESS WIRE)--ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm.
Accolade, Inc. (NASDAQ:ACCD ) Q1 2025 Earnings Conference Call June 27, 2024 4:30 PM ET Company Participants Todd Friedman - SVP of IR Rajeev Singh - CEO Steve Barnes - CFO Conference Call Participants Richard Close - Canaccord Genuity Craig Hettenbach - Morgan Stanley Michael Cherny - Leerink Partners Jeff Garro - Stephens Inc. Ryan Daniels - William Blair Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Ryan MacDonald - Needham & Company Stephanie Davis - Barclays Stan Berenshteyn - Wells Fargo David Larsen - BTIG Jack Wallace - Guggenheim Securities Operator Hello, and thank you for standing by. Welcome to the Accolade First Quarter 2025 Earnings Results Conference Call.
Accolade (ACCD) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.52 per share a year ago.
SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024.
Accolade, Inc. (NASDAQ: ACCD) held its Q4 2024 Earnings Conference Call on April 25, 2024 at 4:30 PM ET. The call featured Todd Friedman, Rajeev Singh, and Steve Barnes from the company, as well as several conference call participants. Thank you for joining the Accolade Fourth Quarter 2024 Earnings Results Conference Call.
Accolade (ACCD) reported a quarterly loss of $0.10 per share, slightly better than the expected loss of $0.11 per share according to the Zacks Consensus Estimate. This is an improvement from the loss of $0.42 per share reported a year ago.
I like Accolade's choice of new partners added year-to-date, as I think the services provided by these partners will be well received by its clients' employees. ACCD's latest "Artificial Intelligence Excellence Award" presented by the Business Intelligence Group provides a validation of the potential AI-related tailwinds for the company. A review of Accolade's most recent developments leaves me bullish on the stock.
What type of business is Accolade?
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
What sector is Accolade in?
Accolade is in the Healthcare sector
What industry is Accolade in?
Accolade is in the Health Information Services industry
What country is Accolade from?
Accolade is headquartered in United States
When did Accolade go public?
Accolade initial public offering (IPO) was on 01 July 2020
What is Accolade website?
https://www.accolade.com
Is Accolade in the S&P 500?
No, Accolade is not included in the S&P 500 index
Is Accolade in the NASDAQ 100?
No, Accolade is not included in the NASDAQ 100 index
Is Accolade in the Dow Jones?
No, Accolade is not included in the Dow Jones index
When does Accolade report earnings?
Next earnings report date is not announced yet